##gff-version 3
##sequence-region O43439 1 604
O43439	UniProtKB	Chain	1	604	.	.	.	ID=PRO_0000218301;Note=Protein CBFA2T2	
O43439	UniProtKB	Domain	113	208	.	.	.	Note=TAFH;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00440	
O43439	UniProtKB	Zinc finger	517	553	.	.	.	Note=MYND-type;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00134	
O43439	UniProtKB	Region	107	215	.	.	.	Note=Interaction with PRDM14;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O70374	
O43439	UniProtKB	Region	331	377	.	.	.	Note=Nervy homology region 2 (NHR2);Ontology_term=ECO:0000305;evidence=ECO:0000305	
O43439	UniProtKB	Region	435	484	.	.	.	Note=Nervy homology region 3 (NHR3);Ontology_term=ECO:0000305;evidence=ECO:0000305	
O43439	UniProtKB	Coiled coil	451	491	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
O43439	UniProtKB	Compositional bias	33	97	.	.	.	Note=Pro-rich	
O43439	UniProtKB	Site	20	21	.	.	.	Note=Breakpoint for translocation to form RUNX1-CBFA2T2 in acute myeloid leukemia;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20520637;Dbxref=PMID:20520637	
O43439	UniProtKB	Modified residue	33	33	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
O43439	UniProtKB	Modified residue	264	264	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
O43439	UniProtKB	Modified residue	409	409	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
O43439	UniProtKB	Modified residue	577	577	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
O43439	UniProtKB	Cross-link	38	38	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
O43439	UniProtKB	Cross-link	449	449	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
O43439	UniProtKB	Alternative sequence	1	29	.	.	.	ID=VSP_008121;Note=In isoform 2 and isoform 3. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15489334,ECO:0000303|PubMed:9787195;Dbxref=PMID:15489334,PMID:9787195	
O43439	UniProtKB	Alternative sequence	1	21	.	.	.	ID=VSP_047410;Note=In isoform 5. MAKESGISLKEIQVLARQWKV->MVGVPGAAAFQL;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
O43439	UniProtKB	Alternative sequence	1	20	.	.	.	ID=VSP_008122;Note=In isoform 4. MAKESGISLKEIQVLARQWK->MGFHHVGQARLELLTSGDLPALASQRAGIT;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
O43439	UniProtKB	Alternative sequence	240	292	.	.	.	ID=VSP_008123;Note=In isoform 3. RREENSFDRDTIAPEPPAKRVCTISPAPRHSPALTVPLMNPGGQFHPTPPPLQ->SCIIHLKSMGVASRHEYFSGTLQMPAHPVRNSTLENLWVDCSRSLRSTVLPFP;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
O43439	UniProtKB	Alternative sequence	293	604	.	.	.	ID=VSP_008124;Note=In isoform 3. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
O43439	UniProtKB	Sequence conflict	31	31	.	.	.	Note=P->H;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O43439	UniProtKB	Sequence conflict	266	266	.	.	.	Note=A->V;Ontology_term=ECO:0000305;evidence=ECO:0000305	
